Concepedia

Johannes Stallhofer

JS

20

Publications

1.5K

Citations

14

H-Index

2007

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

Max Planck Institute of Psychiatry

Medizinische Hochschule Hannover

RWTH Aachen University

LMU Klinikum

Johannes Stallhofer is an author at Ludwig-Maximilians-Universität München specializing in inflammation, immune-mediated inflammatory diseases, and immunodeficiencies.

ORCID

Top concepts

Publications per year

2007–2023

20

Publications

20

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

Julia Seiderer, Ira Elben, Julia Diegelmann et al. · Inflammatory Bowel Diseases · 2007 · 324 citations · Full text

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Cornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich et al. · Gut · 2013 · 296 citations

Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis

Matthias Jürgens, Rüdiger P. Laubender, Franziska Hartl et al. · The American Journal of Gastroenterology · 2010 · 169 citations

Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status

Johannes Stallhofer, Matthias Friedrich, Astrid Konrad-Zerna et al. · Inflammatory Bowel Diseases · 2015 · 122 citations · Full text

Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease

Jürgen Glas, Johannes Stallhofer, Stephan Ripke et al. · The American Journal of Gastroenterology · 2009 · 84 citations

Rows per page

1–5 of 20